99-4390. Extramural Grants for Biomechanics Injury Research; Notice of Availability of Funds  

  • [Federal Register Volume 64, Number 35 (Tuesday, February 23, 1999)]
    [Notices]
    [Pages 8823-8825]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-4390]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Centers for Disease Control and Prevention
    [Program Announcement 99050]
    
    
    Extramural Grants for Biomechanics Injury Research; Notice of 
    Availability of Funds
    
    A. Purpose
    
        The Centers for Disease Control and Prevention (CDC) announces that 
    grant applications are being accepted for Injury Prevention and Control 
    Research Grants (RO1s) for fiscal year (FY) 1999.
        This program addresses the priority areas of Violent and Abusive 
    Behavior and Unintentional Injuries.
        The purpose of this program is to:
        1. Support injury prevention and control research on priority 
    issues as delineated in: Healthy People 2000; Injury Control in the 
    1990's: A National Plan for Action; Injury in America; Injury 
    Prevention: Meeting the Challenge; and Cost of Injury: A Report to the 
    Congress.
        2. Encourage professionals from a wide spectrum of disciplines such 
    as engineering, medicine, health care, public health, health care 
    research, behavioral and social sciences, and others, to undertake 
    research to prevent and control injuries.
        3. Expand the development and evaluation of current or new 
    intervention methods and strategies for preventing and controlling 
    injuries.
        4. Build the scientific base for the prevention and control of 
    injuries and deaths.
    
    B. Eligible Applicants
    
        Applications may be submitted by public and private nonprofit and 
    for-profit organizations and by governments and their agencies; that 
    is, universities, colleges, research institutions, hospitals, other 
    public and private nonprofit and for-profit organizations, State and 
    local governments or their bona fide agents, and federally recognized 
    Indian tribal governments, Indian tribes, or Indian tribal 
    organizations.
        Applicant requirements:
        1. A principal investigator who has conducted research, published 
    the findings in peer-reviewed journals, and has specific authority and 
    responsibility to carry out the proposed project.
        2. Demonstrated experience (on the applicant's project team) in 
    conducting, evaluating, and publishing injury control research in peer-
    reviewed journals.
        3. Effective and well-defined working relationships within the 
    performing organization and with outside entities that will ensure 
    implementation of the proposed activities.
        4. The ability to carry out an injury control research project.
        5. The overall match between the applicant's proposed theme and 
    research objectives and the program interests as described under the 
    heading ``Programmatic Interests.''
    
        Note: Pub. L. 104-65 states that an organization described in 
    section 501(c)(4) of the Internal Revenue Code of 1986 that engages 
    in lobbying activities is not eligible to receive Federal funds 
    constituting an award, grant, cooperative agreement, contract, loan 
    or any other form.
    
    C. Availability of Funds
    
        Approximately $1 million is available for FY 1999 injury research 
    grants that address biomechanics. Approximately 3-5 awards will be 
    made. It is expected that the awards will begin on or about September 
    1, 1999 and will be made for a 12-month budget period within a project 
    period of up to three-years. Funding estimates may vary and are subject 
    to change.
        The maximum funding level per year will not exceed $300,000 
    (including both direct and indirect costs). Applications that exceed 
    the funding cap will be excluded from the competition and returned to 
    the applicant.
    
        Note: Grant funds will not be made available to support the 
    provision of direct care. Eligible applicants may enter into 
    contracts, including consortia agreements (as set forth in the PHS 
    Grants Policy Statement, dated April 1, 1994), as necessary to meet 
    the requirements of the program and strengthen the overall 
    application.
    
    Programmatic Interests:
    
        There is programmatic interest in advancing the biomechanical 
    understanding of traumatic brain and spinal cord injuries (TBI/SCI), 
    thoracic and abdominal injuries resulting from blunt impact, and 
    injuries occurring to the extremities and joints. There is also 
    interest in the biomechanical evaluation of intervention concepts and 
    strategies (e.g., multi-use recreational helmets, mouth and face 
    protection devices for athletes, energy-absorbing playground surfaces, 
    hip pads, motor vehicle side impact and rollover countermeasures, 
    etc.). There is special interest in defining human tolerance limits for 
    injury; the development of biofidelic models to elucidate injury 
    physiology and pharmacologic, surgical, rehabilitation, and other 
    interventions; improvements in injury assessment technology; 
    understanding impact injury mechanisms; and quantifying injury-related 
    biomechanical responses for critical areas of the human body (e.g., 
    brain and vertebral injury with spinal cord involvement). While 
    extending and adapting results and conclusions of the above efforts to 
    the entire population is both desirable and sought, additional 
    consideration will be given to proposals that emphasize research 
    especially applicable to young children, females, and/or the elderly.
    
    D. Application Content
    
        Applicants should follow the PHS-398 (Rev. 5/95) application and 
    Errata sheet, and should include the following information:
        1. The project's focus that justifies the research needs and 
    describes the scientific basis for the research, the expected outcome, 
    and the relevance of the findings to reduce injury morbidity, 
    mortality, disability, and economic losses. This focus should be based 
    on recommendations in Healthy People 2000; Injury in America; Injury 
    Prevention: Meeting the Challenge; and Cost of Injury and should seek 
    creative approaches that will contribute to a national program for 
    injury control.
        2. Specific, measurable, and time-framed objectives.
    
    [[Page 8824]]
    
        3. A detailed plan describing the methods by which the objectives 
    will be achieved and evaluated, including their sequence. A 
    comprehensive evaluation plan is an essential component of the 
    application.
        4. A description of the grant's principal investigator's role and 
    responsibilities.
        5. A description of all the project staff regardless of their 
    funding source. It should include their title, qualifications, 
    experience, percentage of time each will devote to the project, as well 
    as that portion of their salary to be paid by the grant.
        6. A description of those activities related to, but not supported 
    by the grant.
        7. A description of the involvement of other entities that will 
    relate to the proposed project, if applicable. It should include 
    commitments of support and a clear statement of their roles.
        8. A detailed first year's budget for the grant with future annual 
    projections, if relevant. Awards will be made for a project period of 
    up to three years.
        An applicant organization has the option of having specific salary 
    and fringe benefit amounts for individuals omitted from the copies of 
    the application which are made available to outside reviewing groups. 
    To exercise this option: on the original and five copies of the 
    application, the applicant must use asterisks to indicate those 
    individuals for whom salaries and fringe benefits are not shown; the 
    subtotals must still be shown. In addition, the applicant must submit 
    an additional copy of page four of Form PHS-398, completed in full, 
    with the asterisks replaced by the salaries and fringe benefits. This 
    budget page will be reserved for internal staff use only.
    
    F. Submission and Deadline
    
        Submit the original and five copies of PHS 398 (OMB Number 0925-
    0001) (adhere to the instructions on the Errata Instruction Sheet for 
    PHS 398). Forms are in the application kit. On or before April 15, 
    1999, submit the application to: Anne Foglesong, Grants Management 
    Specialist, Grants Management Branch, Procurement and Grants Office, 
    Announcement 99050, Centers for Disease Control and Prevention (CDC), 
    2920 Brandywine Road, Room 3000, Atlanta, Georgia 30341.
        Applications shall be considered as meeting the deadline if they 
    are received at the above address on or before the deadline date; or 
    sent on or before the deadline date, and received in time for the 
    review process. Applicants should request a legibly dated U.S. Postal 
    Service postmark or obtain a legibly dated receipt from a commercial 
    carrier or the U.S. Postal Service. Private metered postmarks shall not 
    be acceptable as proof of timely mailing.
    
    G. Evaluation Criteria
    
        Please take special notice as elements of this section have changed 
    since the last announcement. A more complete description of the grant 
    award selection process policy can be obtained by calling the phone 
    number found under Where to Obtain Additional Information in the 
    application kit.
        Upon receipt, applications will be reviewed by CDC staff for 
    completeness and responsiveness as outlined under the Eligible 
    Applicants, subtitle Applicant Requirements (Items 1-5). Incomplete 
    applications and applications that are not responsive will be returned 
    to the applicant without further consideration. It is especially 
    important that the applicant's abstract reflects the project's focus, 
    because the abstract will be used to help determine the responsiveness 
    of the proposal.
        Applications which are complete and responsive will be subjected to 
    a preliminary evaluation (triage) by a peer review committee, the 
    Injury Research Grant Review Committee (IRGRC), to determine if the 
    application is of sufficient technical and scientific merit to warrant 
    further review by the IRGRC; CDC will withdraw from further 
    consideration applications judged to be noncompetitive and promptly 
    notify the principal investigator/program director and the official 
    signing for the applicant organization. Those applications judged to be 
    competitive will be further evaluated by a dual review process.
        Awards will be determined by the Director of the National Center 
    for Injury Prevention and Control (NCIPC) based on priority scores 
    assigned to applications by the primary review committee, 
    recommendations by the secondary review committee, consultation with 
    NCIPC senior staff, and the availability of funds.
        1. The primary review will be a peer review conducted by the IRGRC. 
    All proposals will be reviewed for scientific merit by a committee of 
    no less than three reviewers with appropriate expertise using current 
    National Institutes of Health (NIH) criteria to evaluate the methods 
    and scientific quality of the proposal. Factors to be considered will 
    include:
        a. The specific aims of the research project, i.e., the broad long-
    term objectives, the intended accomplishment of the specific research 
    proposal, and the hypothesis to be tested.
        b. The background of the proposal, i.e., the basis for the present 
    proposal, the critical evaluation of existing knowledge, and specific 
    identification of the injury control knowledge gaps which the proposal 
    is intended to fill.
        c. The significance and originality from a scientific or technical 
    standpoint of the specific aims of the proposed research, including the 
    adequacy of the theoretical and conceptual framework for the research.
        d. The progress of preliminary studies (optional) pertinent to the 
    application.
        e. The adequacy of the proposed research design, approaches, and 
    methodology to carry out the research, including quality assurance 
    procedures, plan for data management, and statistical analysis plan.
        f. The extent to which the research findings will lead to feasible, 
    cost-effective injury interventions.
        g. The extent to which the evaluation plan will allow the 
    measurement of progress toward the achievement of the stated 
    objectives.
        h. Qualifications, adequacy, and appropriateness of personnel to 
    accomplish the proposed activities.
        i. The degree of commitment and cooperation of other interested 
    parties (as evidenced by letters detailing the nature and extent of the 
    involvement).
        j. Gender and minority issues--Are plans to include both sexes and 
    minoritities and their subgroups adequately developed (as appropriate 
    for the scientific goals of the project)? Are strategies included for 
    the recruitment and retention of human subjects?
        k. Human Subjects--Are the procedures proposed adequate for the 
    protection of human subjects and are they fully documented? Are all 
    procedures in compliance with applicable published regulations?
        l. The reasonableness of the proposed budget to the proposed 
    research and demonstration program.
        m. Adequacy of existing and proposed facilities and resources.
        2. The secondary review will be conducted by the Science and 
    Program Review Work Group (SPRWG) from the Advisory Committee for 
    Injury Prevention and Control (ACIPC). At the SPRWG's request, Federal 
    ex officio members may be invited to attend the secondary review. The 
    Federal ex officio members will be responsible for identifying 
    proposals in overlapping areas of research interest so that unwarranted 
    duplication in federally-funded research can be avoided. At the SPRWG's 
    request, NCIPC Division Associate Directors (ADS) for science may be 
    invited to attend the secondary
    
    [[Page 8825]]
    
    review to assure that research priorities of the announcement are 
    understood and to provide background regarding current research 
    activities. The SPRWG may reach over better ranked proposals in order 
    to assure maximal impact and balance of proposed research. The factors 
    to be considered will include:
        a. The results of the primary review including the proposal's 
    priority score as the primary factor in the selection process.
        b. The match between the proposal and the program announcement's 
    programmatic interests and funding preferences.
        c. The relevance and balance of proposed research relative to the 
    NCIPC programs and priorities.
        d. The significance of the proposed activities in relation to the 
    priorities and objectives stated in Healthy People 2000, Injury in 
    America, Injury Prevention, Meeting the Challenge, and Cost of Injury.
        e. Budgetary considerations.
        Only SPRWG members will vote on funding recommendations. These 
    recommendations will be carried to the entire ACIPC in the form of a 
    report. The ACIPC may vote to approve, disapprove, or modify the 
    recommendations for funding. These recommendations will then be 
    presented to the NCIPC Director for final decision.
        3. Continuation awards made after FY 1999, but within the project 
    period, will be made on the basis of the availability of funds and the 
    following criteria:
        a. The accomplishments reflected in the progress report of the 
    continuation application indicate that the applicant is meeting 
    previously stated objectives or milestones contained in the project's 
    annual workplan and satisfactory progress demonstrated through 
    presentations at work-in-progress monitoring workshops.
        b. The objectives for the new budget period are realistic, 
    specific, and measurable.
        c. The methods described will clearly lead to achievement of these 
    objectives.
        d. The evaluation plan will allow management to monitor whether the 
    methods are effective.
        e. The budget request is clearly explained, adequately justified, 
    reasonable and consistent with the intended use of grant funds.
    
    H. Other Requirements
    
    Technical Reporting Requirements
    
        Provide CDC with an original plus two copies of:
        1. Progress reports (annual);
        2. Financial status report, no more than 90 days after the end of 
    the budget period; and
        3. Final financial status and performance reports, no more than 90 
    days after the end of the project period.
        Send all reports to: Anne Foglesong, Grants Management Specialist, 
    Grants Management Branch, Procurement and Grants Office, Centers for 
    Disease Control and Prevention (CDC), 2920 Brandywine Road, Room 3000, 
    Atlanta, Georgia 30341-4146.
        The following additional requirements are applicable to this 
    program. For a complete description of each see Addendum 1, in the 
    application kit.
    
    AR-1--Human Subjects Requirements
    AR-2 Requirements for Inclusion of Women and Racial and Ethnic 
    Minorities in Research
    AR-9--Paperwork Reduction Act Requirements
    AR-10--Smoke-Free Workplace Requirements
    AR-11--Healthy People 2000
    AR-12--Lobbying Restrictions
    AR-13--Prohibition on Use of CDC funds for Certain Gun Control 
    Activities
    AR-20--Conference Activities within Grants/Cooperative Agreement
    
    I. Authority and Catalog of Federal Domestic Assistance Number
    
        This program is authorized under sections 391(a) and 393(a) of the 
    Public Health Service Act, [42 U.S.C. 280b(a), and 280b-1(a)], as 
    amended. The catalog of Federal Domestic Assistance number is 93.136.
    
    J. Where To Obtain Additional Information
    
        Please refer to Program Announcement Number 99050 when requesting 
    information. To receive additional written information and to request 
    an application kit, call 1-888-GRANTS4 (1-888-472-6874). You will be 
    asked to leave your name and address and will be instructed to identify 
    the Announcement number of interest.
        If you have questions after reviewing the contents of all the 
    documents, business management technical assistance may be obtained 
    from: Anne Fogelsong, Grants Management Specialist, Procurement and 
    Grants Office, Centers for Disease Control and Prevention (CDC), 2920 
    Brandywine Road, Room 3000, Atlanta, Georgia 30341, Telephone: (770) 
    488-2724, Email Address: anf3@cdc.gov.
        For program technical assistance, contact: Ted Jones, Program 
    Manager, Office of Research Grants, National Center for Injury 
    Prevention and Control, Centers for Disease Control and Prevention 
    (CDC), 4770 Buford Highway, NE, Mailstop K-58, Atlanta, GA 30341-3724, 
    Telephone: (770) 488-4824, Email Address: tmj1@cdc.gov
        This and other CDC announcements are available through the CDC 
    homepage on the Internet. The address for the CDC homepage is http://
    www.cdc.gov.
        Interested applicants may receive a draft copy of the ``Policy for 
    Solicitation and Selection of Injury Research Grant Proposals'' by 
    calling 770-488-4265.
    
        Dated: February 17, 1999.
    John L. Williams,
    Director, Procurement and Grants Office, Centers for Disease Control 
    and Prevention (CDC).
    [FR Doc. 99-4390 Filed 2-22-99; 8:45 am]
    BILLING CODE 4163-18-P
    
    
    

Document Information

Published:
02/23/1999
Department:
Centers for Disease Control and Prevention
Entry Type:
Notice
Document Number:
99-4390
Pages:
8823-8825 (3 pages)
Docket Numbers:
Program Announcement 99050
PDF File:
99-4390.pdf